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ABSTRACT
The helicase and RNaseD C-terminal (HRDC)
domain, conserved among members of the RecQ
helicase family, regulates helicase activity by virtue
of variations in its surface residues. The HRDC
domain of Bloom syndrome protein (BLM) is
known as a critical determinant of the dissolution
function of double Holliday junctions by the
BLM–Topoisomerase IIIa complex. In this study,
we determined the solution structure of the human
BLM HRDC domain and characterized its DNA-
binding activity. The BLM HRDC domain consists
of five a-helices with a hydrophobic 310-helical
loop between helices 1 and 2 and an extended
acidic surface comprising residues in helices 3–5.
The BLM HRDC domain preferentially binds to
ssDNA, though with a markedly low binding affinity
(Kd  100kM). NMR chemical shift perturbation
studies suggested that the critical DNA-binding
residues of the BLM HRDC domain are located in
the hydrophobic loop and the N-terminus of helix
2. Interestingly, the isolated BLM HRDC domain
had quite different DNA-binding modes between
ssDNA and Holliday junctions in electrophoretic
mobility shift assay experiments. Based on its
surface charge separation and DNA-binding
properties, we suggest that the HRDC domain of
BLM may be adapted for a unique function among
RecQ helicases—that of bridging protein and DNA
interactions.
INTRODUCTION
Bloom syndrome is a rare hereditary disease characterized
by a predisposition to the development of cancer (1).
Bloom syndrome cells show an  10-fold elevation in the
frequency of sister-chromatid exchanges, which is caused
by mutations in the BLM gene (2,3). Bloom syndrome
protein (BLM) is one of ﬁve human RecQ helicase
family members, all of which play critical roles in DNA
recombination, replication and repair pathways ranging
from bacteria to humans (4,5). The biological importance
of the RecQ family is related to three cancer-prone human
syndromes—Bloom, Werner and Rothmund–Thompson
syndromes—that arise from mutations within the BLM,
WRN and RECQ4 genes, respectively (3,6,7).
The functional signiﬁcance of RecQ helicases is that
they are DNA-speciﬁc enzymes, each binding to a differ-
ent set of DNA structures. BLM has an apparent prefer-
ence for DNA substrates containing Holliday junctions,
G4 DNA and D-loops (8–10). These are highly related to
the cellular functions of BLM, which is involved in the
early and late steps of homologous recombination (HR).
BLM can catalyze efﬁcient Holliday junction branch
migration as an anti-recombinase to prevent genome in-
stability (11–13). BLM is unique among the ﬁve human
RecQ helicases in that it is able to process a double
Holliday junction (dHJ) with Topoisomerase IIIa
(TOPOIIIa) (14). In particular, the helicase and
RNaseD C-terminal (HRDC) domain of BLM is a
critical regulator for dissolution of dHJs by the BLM–
TOPOIIIa complex (15).
BLM contains one unique domain and three conserved
domains of the RecQ helicase family (Figure 1A). The
unique N-terminal domain is not well characterized, but
is involved in BLM oligomerization (16) as well as
protein–protein interactions, including those with
TOPOIIIa (14), Rad51 (17) and RPA (18). The RecQ
family is deﬁned by a highly conserved helicase domain
that includes seven sequence motifs that are distinct from
other helicases. The RQC domain is composed of two
subdomains, one of which is a winged-helix domain
involved in duplex DNA binding, and the other a Zn
2+-
binding motif (19–22). The helicase and winged-helix
domains combine to form the catalytic core, which is suf-
ﬁcient for ATPase and DNA unwinding activities in
Escherichia coli RecQ (23), Saccharomyces cerevisiae
Sgs1 (24) and human BLM (25). C-terminal to the cata-
lytic core, the HRDC domain forms an independent
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particularly in conferring some degree of DNA substrate
speciﬁcity. Of the three conserved sequence elements of
the RecQ proteins, the HRDC domain has the lowest
sequence identity between family members (26).
The structures of isolated HRDC domains from E. coli
RecQ (27), S. cerevisiae Sgs1 (28), human WRN (29) and
Deinococcus radiodurans RecQ (DrRecQ) (30), all share
a similar overall fold but exhibit distinct functions.
For example, the isolated Sgs1 HRDC domain binds to
ssDNA and 30-overhanging duplex structures, whereas the
E. coli RecQ HRDC binds only to ssDNA. In contrast to
unicellular RecQ HRDC domains, which function via
auxiliary contacts to DNA, the WRN and BLM HRDC
domains have been suggested to mediate diverse molecular
interactions via their electrostatic surfaces properties (28).
Figure 1. Structure of the human BLM HRDC domain. (A) Schematic diagram of conserved domains in full-length BLM: helicase, RQC and
HRDC. The N-terminal region is an intrinsic domain for protein–protein interaction and oligomerization of BLM. (B) Sequence alignment of the
HRDC domain of BLM, WRN, Sgs1 and E. coli RecQ based on their 3D structures. Secondary structural elements (helices) are shown below each
sequence as blue (BLM, present work) or grey (WRN, SGS1, E. coli RecQ) bars. Loop regions are shown as a solid line, whereas the disordered
residues at the C-termini of BLM and WRN HRDC are shown as a dashed line. The BLM, Sgs1 and E. coli residues that were reported to affect
ssDNA binding are highlighted in yellow. The residues of human BLM that affect DNA binding are denoted by blue and green circles, and the
residues that contribute to the acidic surface of BLM HRDC are indicated by red circles. A conserved acidic pin motif is indicated with red and blue
bold letters. The four residues of the conserved hydrophobic core of HRDC homologues are denoted by orange circles. (C) Stereoviews of the
ensemble of the 20 lowest-energy NMR structures. (D) 3D representative structure of the human BLM HRDC domain in the same orientation as in
(C). (E) Ribbon diagram of the four residues of the conserved hydrophobic core, Leu1222, Leu1246, Leu1249 and Leu1282, of the human BLM
HRDC domain.
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WRN HRDC domain did not interact with DNA and
suggested instead that it mediates protein–protein inter-
actions (29). However, the HRDC domain of BLM is
known as a critical determinant for the efﬁcient binding
to and unwinding of dHJ DNA by the BLM–TOPOIIIa
complex. Furthermore, Lys1270 of the HRDC domain is
highly likely to play a role in mediating interactions with
DNA (15). A recent study showed that unusual electro-
static surface of the third HRDC domain of DrRecQ
(DrRecQ HRDC #3) is important to regulate structure-
speciﬁc DNA binding and help direct DrRecQ to speciﬁc
recombination/repair sites (30).
To more accurately characterize the DNA-binding
properties of BLM HRDC, we have studied the structure
and DNA-binding activity of the human BLM HRDC
domain by NMR spectroscopy and electrophoretic
mobility shift assays (EMSAs). The BLM HRDC
domain formed a bundle of ﬁve a-helices, similar to the
other HRDC homologues, but had an extended acidic
surface that was highly distinct from the remaining, pre-
dominantly hydrophobic surface area. BLM HRDC spe-
ciﬁcally bound to single-stranded DNA (ssDNA), mainly
using its 310-helical hydrophobic loop and the N-terminal
region of helix 2. In EMSAs of several BLM HRDC
variants, we observed that the isolated BLM HRDC
domain had quite different DNA-binding modes with
ssDNA versus Holliday junction. Based on these
ﬁndings, we propose that the human BLM HRDC
domain may be adapted to play a distinct role in BLM
that involves protein–DNA interactions.
MATERIALS AND METHODS
Cloning and protein puriﬁcation
The cDNA encoding the human BLM HRDC domain
(residues 1210–1294) was ampliﬁed by PCR from
pJK1DNA (a kind gift from Dr Ian Hickson of Oxford
University) (4) using the following two primers that were
purchased from Bioneer, Inc. (Daejeon, Korea): forward
(50-GCGCATATGCAGAGG GAAGAG ATGGTT-30)
and reverse (50-GCGCTCGAGTCAGTCTTCAGCTGG
CGATGT-30). The ampliﬁed DNA fragment was
digested with Nde I and Xho I and was inserted into a
pET15b plasmid encoding an N-terminal hexa-His tag
fusion protein (namely, pET15b-BLMHRDC). The
plasmid sequence was conﬁrmed by DNA sequencing
(Genotech, Korea). Escherichia coli strain BL21 (DE3)
pLysS (Stratagene) was transformed with pET15b-
BLMHRDC and used for protein production. Cells were
grown at 37 C in Luria-Bertani (LB) broth or M9 minimal
medium. For protein expression, cells were grown at 30 C
and induced with 0.4mM Isopropyl b-D-1-thiogalacto-
pyranoside (IPTG). Isotopic labeling of all proteins was
carried out by growing the cultures in modiﬁed minimal
medium containing 1g/l
15NH4Cl and/or 2g/l
13C-glucose
as nitrogen and/or carbon sources, respectively (CIL Inc.).
After cell resuspension in 25mM Tris–HCl (pH 8.0),
500mM NaCl, 10mM b-mercaptoethanol and 0.2%
Triton X-100, proteins were initially puriﬁed by a
Ni–NTA column (Quiagen Inc.). Following dialysis of
the eluted, pooled protein fractions in 25mM Tris–HCl
(pH 7.5), 100mM NaCl and 5mM b-mercaptoethanol,
the histidine tag was removed by an overnight incuba-
tion with thrombin protease at room temperature and a
second round of Ni–NTA chromatography to remove
the fusion tags. Further puriﬁcation of the protein was
carried out using a Q Sepharose column (Amersham
Biosciences) to remove nucleic acids and a HiLoad 16/60
Superdex 75 gel-ﬁltration column (Amersham Biosciences)
pre-equilibrated with buffer A (20mM HEPES, pH 7.0,
100mM NaCl, 1mM DTT). The purity and homogeneity
of all samples were conﬁrmed by SDS–PAGE. For NMR
measurements, the samples were concentrated to 0.8–
1.2mM in Buffer A with 1mM EDTA and 0.02% NaN3
(in 90% H2O/10% D2O or 100% D2O) using an Amicon
Ultra-15 ﬁlter (5000 MWCO, Millipore).
DNA substrates
DNA substrates purchased from Bioneer, Inc. (Daejeon,
Korea) were: 1SD* (50-GCGCATATGGAGCGTTTCC
AAAGTCTTAG-30: 29nt) and 2DD (50-CTAAGACTTT
GGAAACGCTCCATATGCGC-30: 29nt). 1SD* and
2DD were used to make the double-stranded (ds) DNA
substrate; 1SD* was used for the ssDNA substrate; and
the synthetic HJ DNA (4X-12) consisted of four 50-nt
oligonucleotides (31,32) and prepared as described by
Mohaghegh et al. (8). The structure of the prepared HJ
DNA was that of mobile HJ with a homologous core and
25bp on each arm (8,33). For each substrate a single oligo-
nucleotide (*) was 50-end-labeled with [g-
32P] ATP (speciﬁc
activity, >3000Ci/mmol, NEN Radiochemicals) using T4
polynucleotide kinase (Takara, Inc.) The labeled oligo-
nucleotides were dissolved in 10mM Tris–HCl (pH 7.5)
buffer with 0.1M NaCl and 1mM EDTA and annealed
to their unlabelled complementary strand by incubation
at 95 C for 5min and slowly cooled to room temperature
for  1h. For puriﬁcation, unincorporated label was
removed by Sephadex G-50 resin. All substrates were gel
puriﬁed by electrophoresis through 12% non-denaturing
PAGE (37.5:1), visualized and isolated from the gel slice
using the standard crash/soak method (34) of elution
[10mM Tris–HCl (pH 7.5),1mM MgCl2, 1mM EDTA
and 350mM NaCl], followed by precipitation with
EtOH. Samples were then dissolved in TEN buffer
[10mM Tris–HCl (pH 8.0), 10mM EDTA, 50mM NaCl].
A DNA substrate purchased from the IDT, Inc. (San
Diego, CA, USA) was: 3SD-11(50-TCATTCAGAGT-30:
11nt). 3SD-11 was used as the substrate for NMR titra-
tion. The purity and homogeneity of the products were
conﬁrmed by matrix-assisted laser desorption ionization
mass spectroscopy. It was dialyzed into protein buffer
(25mM HEPES, pH 7.0, 100mM NaCl and 1mM
EDTA) for 12h. DNA concentrations were determined
by measuring absorbance at 260nm.
NMR spectroscopy and structure calculation
All NMR spectra were recorded at 298K on a Varian
INOVA 600MHz spectrometer (KAIST, Daejon) and
a Bruker AVANCE 800MHz spectrometer (Korea
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assignments of human BLM HRDC were obtained by
using a combination of standard triple resonance experi-
ments (35). All spectra were processed with NMRPipe
software (36) and analyzed with SPARKY3 version
3.113 software (T.D. Goddard and D.G. Kneller,
SPARKY 3, University of California, San Francisco,
CA, USA). Distance constraints were derived from
3D simultaneous
13C- and
15N-NOESY experiments
acquired with a mixing time of 120ms. Structure calcula-
tions were initially performed using CYANA program
version 2.1, which combines automated assignment of
NOE cross-peaks and structure calculation (37). The
initial CYANA structure calculations were performed
by including backbone torsion angle constraints (j and
c) from TALOS (38). Among the 100 independently
calculated structures, the 20 conformers with the lowest
CYANA target function values and that were most con-
sistent with the experimental restraints were used for
further analyses. Structures with the lowest NOE
energies were retained and validated using PROCHECK
(39). Structures were analyzed and visualized using
PyMOL (DeLano Scientiﬁc LLC, San Carlos, CA) and
MOLMOL (40).
NMR titration and backbone
15N relaxation
For the NMR titration experiments, the 3SD-11 DNA
substrate was added to a 0.5mM sample of BLM
HDRC domain to achieve ﬁve titration points with
the protein:DNA ratios 1:0.5, 1:1, 1:1.5, 1:2, and 1:2.5.
2D HSQC spectra were recorded at each titration
point. Combined
15N-
1H chemical shift differences
were calculated using the equation  =[(0.125 N)
2+
 H
2]
1/2.
The measurements of the nitrogen relaxation times, T1,
T2 and
15N–
1H NOEs were performed at 298K for the
protein alone and the DNA-bound protein on a Varian
INOVA 600MHz spectrometer (41). Ten different values
for the relaxation delay were used for the T1 (delays
50, 100, 150, 200, 250, 300, 400, 500, 700 and 900ms)
and T2 (Carr-Purcell-Meiboom-Gill mixing times 10, 30,
50, 70, 90, 110, 130, 150, 170 and 190ms) relaxation ex-
periments. The T1 and T2 values were extracted using a
curve-ﬁtting subroutine included in the Sparky program.
The
15N-
1H NOE values were calculated as the ratio of the
intensities of paired
15N–
1H correlation peaks from
interleaved spectra acquired with and without
1H
presaturation during a recycle time of 2.5s.
EMSA
For DNA interaction studies using the EMSA, ﬁve
variants of the pET15b-BLMHRDC plasmid were made
according to the site-directed mutagenesis by PCR method
(42), and the sequences of these mutants were conﬁrmed
by DNA sequencing. All mutant protein samples were
puriﬁed like the wild-type (WT) one and ﬁnally dialyzed
in 50mM Tris–HCl (pH 7.5) buffer with 0.1M NaCl,
1mM DTT and 50% glycerol. To obtain accurate
protein concentrations, we measured the concentration
of the HRDC variants using the BCA protein assay
(Pierce, USA).
Puriﬁed human BLM HRDC variants (WT, K1227E,
Y1237A, N1239D, T1243A and V1244A) were incubated
with
32P-labeled DNA substrates in a binding buffer of
50mM Tris–HCl (pH 7.5), 50mM NaCl, 0.1g/l BSA,
1mM DTT, 1mM MgCl2 and 4% glycerol for 25min at
4 C. The concentrations of the proteins and the DNA
substrates used in EMSA experiments are described in
the ﬁgure legends. For the competition experiments, the
puriﬁed human BLM HRDC variants were pre-incubated
with  50 unlabeled competitor DNA substrate in a 20ml
volume of binding buffer for 10min on ice. End-labeled
DNA probes were then added to the reaction mixtures.
After incubating for 20min, the mixtures were separated
by 6% native PAGE. Prior to loading, gels were pre-run at
6.5V/cm for 15min, and electrophoresis was performed in
0.5 TBE (54mM Tris borate pH 8.3, 1mM EDTA) for
40min to 1h. The gel was dried onto Whatman paper and
analyzed with BAS-1500 (Fuji). The concentrations of
bound and free probe were quantiﬁed by the calibration
tool of TINA 2.09g software (Raytest Isotopentechnik
GmbH) and ﬁt to the equation for a single binding site
(Kd=[R][P]/[RP], where [PR] is the concentration of
DNA–protein complex, [P] that of protein concentration
and [R] that of unbound DNA) given by Black et al. (43).
RESULTS
Identiﬁcation and characterization of the human
BLM HRDC domain
The structures of the isolated HRDC domains from E. coli
RecQ, Sgs1 and human WRN all share a similar overall
fold—a ﬁve a-helical bundle (27–29). However, it is difﬁ-
cult to determine domain constructs for human BLM
because of its low sequence homology (<25%) to the
other RecQ family members (Figure 1B). There are two
reports identifying the mammalian HRDC domain by
comparing its sequence homology with orthologs
(28,29). From a sequence alignment with mouse, chicken
and Xenopus BLM, we hypothesized that the human
BLM HRDC construct should comprise residues
Gln1210 to Asp1294 (Supplementary Figure S1). This
construct was predicted by the ExPASy ProtParam tool
(http://www.expasy.ch/tools/) to have a much lower pI
(4.8) than the pH 7.0 buffer normally used in NMR ex-
periments, which predicts a protein amenable to structural
study by NMR. Over-expression of this recombinant
BLM HRDC fragment in E. coli yielded 100mg from 1l
LB media. The low efﬁciency of thrombin digestion
and limited proteolysis using subtilisin indicated that this
construct is very stable and structurally compact
(Supplementary Figure S2). Finally, 20 and 10mg of
puriﬁed HRDC were obtained from 1l of LB and M9
media, respectively. CD (Jasco-810) spectral analysis
of the protein indicated that the fragment contains a
high amount of a-helical content (Supplementary
Figure S3).
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We ﬁrst analyzed the human BLM HRDC domain using
multidimensional NMR spectroscopy. Experimental data
and structural statistics are summarized in Table 1.
In total, assignments of 98.8% of the main-chain and
96.4% of the side-chain atoms of residues 1210–1294
were completed. Among all the backbone resonances,
only those of Phe1238 were not assigned due to resonance
overlap; however, its side-chain resonances were resolved.
Figure 1C represents the ﬁnal 20 conformers that adopt
a well-deﬁned tertiary structure in range from residues
1210 to 1294 except for several C-terminal residues and
it was reﬁned to a root mean square deviation (RMSD) of
0.35A ˚ for backbone atoms. The ribbon diagram of the
human BLM HRDC domain clearly shows that the
BLM HRDC consists of ﬁve a-helices and one 310 helix
in a hydrophobic loop (Figure 1D). A search for proteins
with similar conﬁgurations was carried out using the
DALI search engine (44). The human BLM backbone
structure was superimposable on those of E. coli RecQ
(27), DrRecQ (30), human WRN (29) and Sgs1 (28)
with RMSDs of 1.5, 1.7, 1.7 and 2.7A ˚ , respectively (for
74Ca,7 8 C a,7 8 C a and 77Ca atoms, respectively). The
residues that make up the hydrophobic core of HRDC
domains are represented in Figure 1E. In the case of
human BLM, Leu1222, Leu1246, Leu1249 and Leu1282
are the key hydrophobic residues holding the helical
bundle structure together. The identity of these core
residues diverges somewhat from other RecQ family
members, as does the sequence for the 310 helix.
Speciﬁcally, the hydrophobic core in the three other
HRDC homologues consists of Leu, Leu, Met and Ile
residues (Figure 1B), and the hydrophobic linker
between a-helices 1 and 2 begins as 1173-VPPX-1176 in
WRN, Sgs1 and E. coli RecQ (numbered for WRN; X is
Ala, Val or Tyr) as opposed to 1235-VHYF-1238 in BLM.
The secondary structure of the hydrophobic linker is
divergent in the RecQ family and difﬁcult to predict
from the sequences; a loop structure is formed in Sgs1
(28), whereas a more compact 310 helix is formed in
E. coli (27) and WRN (29). The BLM HRDC structure
clearly showed that BLM adopts a 310 helix structure
similar to that of E. coli RecQ and WRN. For E. coli
HRDC, 310 helix formation might be important in
exposing the aromatic ring of Tyr555 to solvent for inter-
action with ssDNA (27). In the structure of BLM HRDC,
Tyr1237 resides at the corresponding position in the
hydrophobic loop.
The BLM HRDC domain contains an extended
acidic surface
The electrostatic surface potential of BLM HRDC is
shown in Figure 2A. The surface can almost be neatly
divided into two halves, where one side of the domain is
extensively negatively charged (Figure 2A, panel i), and
the other is mostly neutral with a few positively charged
spots (Figure 2A, panel ii). The ‘top’ view (Figure 2A,
panel iii) shows clearly that the concentration of acidic
residues is at the C-terminal end of the construct and on
a surface comprising a-helices 3 to 5. Several acidic
residues, including D1256, E1258, E1268, E1269, E1272,
E1276 and E1288, contribute to the domain’s large elec-
tronegative surface.
The pronounced electronegativity of the BLM HRDC
domain has been predicted by modeling, which suggested
that the function of BLM HRDC is related to protein–
protein interactions (28). However, a study demonstrating
the strong regulatory function of the HRDC domain in
dHJ dissolution by the BLM–TOPOIIIa complex leaves a
possibility for its DNA-binding ability (15). Not only that,
the recently determined the crystal structure of the third
HRDC domain of DrRecQ (DrRecQ HRDC #3, PDB_
2RHF) shows that its highly negatively charged surface
can affect DNA-binding activity and unwinding efﬁciency
for partial duplex DNA substrates (30). In Figure 2B, we
have displayed the surface charge distributions of DrRecQ
HRDC #3 to compare with human BLM HRDC domain
as in Figure 2A. Surface depictions of the DrRecQ HRDC
#3 show a large negative surface extending from helices 1
to 5 in panel i. Panel ii shows that the DrRecQ HRDC #3
is partially hydrophobic and has positive charges around
helices 1, 2 and 4. But it also has a narrow negative patch
along helix 3. The top view (Figure 2B, panel iii) shows
clearly that the negative surface area of DrRecQ HRDC
#3 is larger than that of human BLM HRDC. Figure 2C
shows the sequence similarity between human BLM and
DrRecQ #3 HRDC domain using Kalign (45,46). The
sequence alignment data indicates that these domains
contain 13 acidic residues ranging from helices 1 to 5,
although they have low sequence identity ( 23%). Five
acidic residues of human BLM, i.e. E1213, E1224, E1268,
E1272 and E1287, are located in almost same position
with D753, E760, E804, E808 and D823 of the DrRecQ
HRDC #3 domain.
In our study, although the BLM HRDC domain has a
net negative charge at neutral pH, the charge distribution
around the hydrophobic loop is balanced, as shown in
Figure 2A (panel ii). Furthermore, the sequence of the
hydrophobic linker region contains a strategically placed
Tyr 1237, which may facilitate DNA binding. Thus, we
Table 1. Structural statistics for human BLM HRDC domain
NOE distance restraints
All 1146
Short range (|i j| 1) 641
Medium range (1<<|i j|<5) 309
Long range (|i j|>5) 196
Hydrogen bonds distance restraints (n)3 2
Dihedral angle constraints (n) 114
CYANA target function (A ˚ 2) 0.89
RMSDs from the average coordinate
Backbone atoms (N, Ca and C) (A ˚ ) Helix only
a: 0.35±0.06
Heavy atoms (A ˚ ) Helix only
a: 0.97±0.08
Ramachandran plot (%)
Most favored regions 89.3
Additional allowed regions 10.3
Generously allowed regions 0.1
Disallowed regions 0.0
aHelix regions indicate helix 1 (aa 1211–1233), 310 helix (aa 1237–1240),
helix 2 (aa 1243–1252), helix 3 (aa 1257–1262), helix4 (aa 1268–1273)
and helix 5 (aa 1275–1284).
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BLM HRDC domain.
The human BLM HRDC domain can interact with DNA
To test whether the human BLM HRDC domain can bind
to DNA, we carried out an EMSA. In these experiments,
BLM HRDC was added to radiolabeled ssDNA or
dsDNA substrates, and DNA bound by the domain was
separated from free DNA by electrophoresis. Surprisingly,
this analysis showed that the HRDC domain was able to
bind to ssDNA with a Kd of  100mM (Figure 3A), which
is almost 40 times weaker than the afﬁnity of E. coli RecQ
HRDC for ssDNA (27). In contrast, Figure 3B shows that
the dsDNA substrate was not bound at all by the BLM
HRDC domain, comparable to the results for E. coli
RecQ HRDC (27).
To conﬁrm the DNA-binding properties of the BLM
HRDC domain, we also measured chemical shift
changes in the NMR spectra of
15N-labeled BLM
HRDC upon addition of ssDNA (3SD-11 in ‘Materials
and Methods’ section). Signiﬁcant spectral changes were
observed with increasing DNA concentration, indicating
that the BLM HRDC domain interacts with ssDNA. The
backbone amides of Lys1227, His1236, Tyr1237, Asn1239,
Thr1243, Val1244, Leu1246, Asp1264 and Gly1265 dis-
played the largest chemical-shift changes (>0.042ppm)
upon addition of the ssDNA (Figure 3C). The majority
Figure 2. Comparative surface depiction between human BLM and DrRecQ HRDC #3. (A) Surface depiction of the human BLM HRDC domain
showing the surface charge separation, with (i) an extended negative surface comprising helices 3–5, (ii) a neutral surface comprising helices 1 and 2,
and (iii) the 310 helical hydrophobic loop connecting them. (B) Surface depiction of DrRecQ HRDC #3 domain (PDB_2RHF) showing the
predominant negative surface, with (i) a large negative surface covering helices 1–5, (ii) a sectional positive and neutral surface comprising helix
1 and helix 2 in hydrophobic loop and (iii) helix 4. The protein surfaces are colored by its electrostatic surface potential at ±5 kBT/e for positive
(blue) or negative (red) charge potential using PyMol (Delano Scientiﬁc, San Carlos, CA, 2002). (C) Sequence alignment of the HRDC domains of
BLM and DrRecQ HRDC #3 (DrRecQ#3) based on their charged residues and secondary structure. Each rectangle denotes a helix of BLM (blue) or
DrRecQ#3 (orange). The identical residues are colored in cyan, and the hydrophobic and positive charged residues are colored in grey. The negative
charged residues are denoted by red-colored dots and underlined acidic residues belong to the conserved acidic patch of DrRecQ HRDC #3. The
helix numbering of DrRecQ is according to (30).
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shift were located in three regions of the BLM HRDC
domain: the C-terminal end of helix 1, the 310 hydropho-
bic loop and the N-terminal end of helix 2, and ﬁnally a
short loop between helices 3 and 4 (Figure 3D).
We have indicated the DNA-binding residues of three
HRDC homologues in Figure 1B. In BLM, the His1236,
Tyr1237 and Asn1239 residues are three major binding
residues in the hydrophobic 310 helix. As mentioned
above, the Tyr555 residue of E. coli RecQ HRDC is im-
portant for ssDNA binding (27), and is in the same struc-
tural location as Tyr1237 of BLM HRDC (Figure 1B).
The Lys1227 residue in helix 1 of BLM is located similarly
to a group of four ssDNA-binding residues in RecQ (28).
However, the remaining ssDNA-binding residues of BLM
HRDC are distinct from the other RecQ helicases. There
are also differences in the distribution of basic and hydro-
phobic surface residues, which can easily interact with the
phosphate backbone and exposed bases of the ssDNA,
among the HRDC homologues.
Dynamics study of the BLM HRDC domain
The conformational equilibrium detected in the 310-helical
hydrophobic loop was also observed in the NMR
relaxation parameters (Figure 4). It was most clearly
observed in the R2 values, especially for Val1235,
Tyr1237 and Phe1241, since they are sensitive to slower
(micro- to millisecond time scale) motions. However, the
R1 values also showed signiﬁcant changes in the hydro-
phobic loop, and particularly Tyr1237, compared to the
rest of the protein sequence, in both the free HRDC and
the DNA-bound complex. The average NOE values were
almost the same (within the standard deviations) in the
presence and absence of DNA for the 80 residues with
measurable NOE relaxation data. Because of this, we
conclude that the hydrophobic interaction between the
BLM HRDC domain and ssDNA did not alter the
overall structure of HRDC.
Exploration of DNA-binding residues for different
DNA substrates
Next, we focused on the residues which are important for
the DNA-binding ability of the human BLM HRDC
domain to interpret the EMSA data in light of the struc-
tural data. Residues whose chemical shifts were perturbed
>0.042ppm and that were located on the surface of
BLM HRDC were chosen for mutational analyses
(Figure 5A). We designed seven mutant constructs of
Figure 3. DNA-binding activity of the isolated human BLM HRDC domain. The BLM HRDC domain (0.6, 1.25, 2.5, 5, 10, 20 and 40mM) was
incubated with (A) 0.5nM ssDNA or (B) 0.5nM dsDNA. Free DNA and HRDC/DNA complexes were separated by PAGE and are indicated.
Control lanes in which the HRDC domain was excluded are indicated with a ‘–’ symbol. (C) Superposition of 2D
1H,
15N HSQC spectra of 0.5mM
15N-labeled BLM HRDC, with (red) and without (black) 1:2.5 ssDNA (3SD-11) recorded on a 600MHz spectrometer. The perturbed residues over
0.042ppm are indicated with red type and arrows and other positive, hydrophobic residues labeled with black type. (D) By-residue chemical shift
perturbations of the human BLM HRDC domain upon DNA binding. Perturbations greater than 0.042ppm are indicated by red bars. The
secondary structure of BLM HRDC is shown schematically above the panel.
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D1264A and G1265R (His1236 was not analyzed
because its backbone resonances were not clearly visible,
and Leu1246 is a hydrophobic core residue). Two of them
(D1264A and G1265R) were expressed at very low levels,
so we used only the remaining ﬁve HRDC variants for
further studies by EMSA.
To investigate the possibility of misfolding, we selected
two HRDC variants—Y1237A, which showed the largest
change in R1 and R2 values in dynamics study, and
Thr1243A, which had the largest chemical shift changes
in NMR titration experiment—for measurement of
2D
1H,
15N-HSQC spectra in EMSA buffer (25mM
Tris–HCl (pH 7.5), 100mM NaCl and 1mM DTT)
except for the 50% glycerol. During puriﬁcation, the gel
ﬁltration results conﬁrmed that these two HRDC variants
(Y1243A and T1243A) are the same as the WT BLM
HRDC and do not oligomerize in EMSA buffer
(Supplementary Figure S4). And the peak sharpness and
well-dispersed
1H-
15N HSQC spectra of the HRDC
variants (WT, Y1237A and T1243A) showed also that
the proteins have been well folded in EMSA buffer
(Figure 5B). However, surprisingly, the superposition of
1H-
15N HSQC spectra of the three HRDC variants (WT,
Y1237A and T1243A) showed clearly that several peaks in
both Y1237A (red colored peaks) and T1243A (blue
colored peaks) underwent large chemical shift perturb-
ations compared to the WT spectra in EMSA buffer
(Figure 5B). Because the WT BLM HRDC did not show
chemical shift changes in EMSA buffer except for some of
terminal residues (data not shown), we have assigned the
1H-
15N HSQC spectra of Y1237A and T1243A based
on previous assignment result. By analysis of chemical
shift perturbation of Y1237A and T1243A mutant in
comparison with the WT, we have mapped the locations
of perturbed peaks in the structure of BLM HRDC
(Supplementary Figure S5). Most of the changes in
chemical shifts were concentrated in and around the 310
hydrophobic loops in both Y1237A and T1243. Notably,
the Y1237A mutant has a larger chemical shift change
than T1243A, and its perturbations cover a wider range
in the sequence (from the C-terminal end of helix 1,
through the 310 hydrophobic loop and the N-terminal
helix 2). Most likely, these perturbations have been
mainly caused by micro-environmental changes affected
by the disappearance of the bulky and hydrophobic ring
of Y1237, not by the severe change of protein fold (47). In
Figure 5B, we display two representative residues
(including the Gly1230 and Asn1239; denoted by the
ﬁrst and third dotted-circle from the above, respectively),
which had been moved largely in both of Y1237A and
T1243A mutant. We have also represented that Tyr1237
residues (the second dotted circle) were obviously dis-
appeared in the Y1237A spectrum and also have been per-
turbed largely in T1243A spectrum. Interestingly, Thr1243
peak was disappeared even in Y1237A spectrum that
means that two residues are structurally in reciprocal
action (or effective to each other).
Figure 5C showed the differences of ssDNA-binding
activity of ﬁve HRDC variants. Among the ﬁve variants
Figure 4. Backbone dynamics data for free (ﬁlled circles) and ssDNA-bound (open circles) human BLM HRDC. Residues for which resonances
overlapped (Phe1238 and Trp1288) and C-terminal residues (1291–1294) are not shown. (A) R2 transverse rates, (B) R1 longitudinal relaxation rates
and (C)
1H-
15N heteronuclear NOE values. All data were collected at 600MHz and 298K.
Nucleic Acids Research, 2010,Vol.38, No. 21 7771Figure 5. EMSA analysis and schematic diagram of ﬁve BLM HRDC variants involved in ssDNA and HJ DNA binding. (A) Ribbon diagram with
chemical shift perturbations of the human BLM HRDC domain upon DNA binding. Perturbations greater than 0.04, 0.06 and 0.08ppm are mapped
onto the structure of BLM HRDC in red, yellow and blue color with side chain, respectively. Perturbed but not mutated residues (H1236 and L1246)
are especially labeled in gray color. (B) Superposition of 2D
1H,
15N HSQC spectra of BLM HRDC variants (WT: black-colored peaks; Y1237A:
red-colored peaks; T1243A: blue-colored peaks). The spectra were acquired by Varian INOVA 600 machine (‘Materials and Methods’ section: NMR
spectroscopy) with 1mM protein samples in 25mM Tris–HCl (pH 7.5), NaCl 100mM with 1mM DTT at 298K. The major perturbed residues
(Gly1230:G1230, Tyr1237:Y1237, Asn1239:N1239 and Thr1243: T1243) are labeled and denoted by dashed circle. (C) ssDNA-binding test of each
HRDC variants to 0.1nM ssDNA. The protein concentrations were: WT: 13.2, 26.4, 39.6, 52.8, 66 and 79.2mM; K1227E: the same concentration
with WT; Y1237A: 12.6, 25.2, 37.8, 50.4, 63 and 75.6mM; N1239D: 14.3, 28.6, 42.9, 57.2, 71.5 and 85.8mM; T1243A: 11.9, 23.8, 35.7, 47.6, 59.5 and
71.4mM and V1244A: 13.3, 26.6, 39.9, 53.2, 66.5 and 79.8mM. Free DNA and HRDC variant/DNA complexes are indicated. Control lanes in which
the HRDC domain was excluded are indicated with a ‘ ’ symbol, and lanes in which the 50 times non-labeled DNA was added are indicated with a
‘+’ symbol. (D) HJ DNA-binding test of each HRDC variant to 1nM HJ DNA. The protein concentration were: WT: 0.4, 0.8, 1.6, 3.2, 6.5 and
13mM; K1227E: same concentration with WT; Y1237A: 0.4, 0.8, 1.6, 3.2, 6.3 and 12.6mM; N1239D: 0.45, 0.9, 1.8, 3.6, 7.2 and 14.3mM; T1243A;
0.38, 0.76, 1.5, 3.0, 6.0 and 11.9mM and V1244A: 13.3, 0.8, 1.7, 3.3, 6.6 and 13.3mM. Free DNA and HRDC variant/DNA complexes are indicated.
To simplify the ﬁgures, we denoted the representative concentration of the WT protein for ssDNA and HJ DNA substrates. All experiments were
done multiple times, and the data shown are representative.
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afﬁnities: N1239D and V1244A. The K1227E variant also
showed rather weaker binding than the WT BLM HRDC.
However, the Y1237A and T1243A variants retained at
least nominal ssDNA afﬁnity in compare with WT. The
estimation of dissociation constants (Kd) from measuring
the gel-band volumes shown in Figure 5C showed relative
diffrences among ﬁve HRDC variants although they did
not give clear Kd value because of very weak binding
( 100mM) (Supplementary Figure S6).
To establish whether the HRDC is a conserved HJ
DNA-binding domain, we analyzed HJ DNA binding by
the HRDC domain of human BLM in Figure 5D. By in-
tensive binding tests with WT BLM HRDC for HJ DNA,
we have found that the complex band of BLM HRDC-HJ
DNA was the oligomerized band which could not resolve
from the well. Indeed, the formation of complex band has
started at even 6mM which suggested that the HJ binding
of BLM HRDC is much favorable to ssDNA. Among the
variants tested, three had apparent changes in their HJ
DNA-binding afﬁnities compared to the WT domain:
Y1237A, T1243A and V1244A: mutation of the conserved
Thr1243 resulted in a particularly severe reduction of HJ
DNA binding at high concentration. Interestingly,
mutation of Tyr1237 and Val1244 led to enhancement of
HJ binding that was distinguishable from the other
variants and from WT BLM HRDC. This suggests that
the formation of oligomers is due to an interaction
between the HRDC variants and HJ DNA with different
tendencies.
It is not simple to explain why the isolated BLM HRDC
have different binding modes between ssDNA and HJ
DNA among ﬁve HRDC variants. By the changes of the
1H-
15N HSQC spectrum of Y1237A and T1243A mutants
in Figure 5B, we could suggest that these binding differ-
ences have been caused by the combination of structural
change of binding site of each HRDC variant and
electro-charge changes of protein surface among them.
DISCUSSION
HRDC domains adapt for different DNA-binding modes
Since the ﬁrst structural study of the Sgs1 HRDC (28)
domain suggested it functioned as an auxiliary
DNA-binding domain, three more crystal structure of
HRDC homologues have been determined, including
those from E. coli RecQ (27), human WRN (29) and
DrRecQ (30). All HRDC domains have a very similar
helical bundle structure, but they have different surface
charge distributions and DNA-binding abilities. Sgs1
and E. coli RecQ HRDC domains bind preferentially to
ssDNA over duplex DNA, whereas human WRN cannot
bind even to ssDNA. In this study, we demonstrated that
the isolated BLM HRDC domain also binds preferentially
to ssDNA by using a binding site that includes, at
minimum, Lys1227, Tyr1237, Asn1239, Thr1243 and
Val1244 (Figure 6A). However, these residues form an
almost entirely hydrophobic region (with the exception
of the positively charged Lys1227) on the surface of
BLM, making the interaction markedly weak (Kd
 100mM) compared with E. coli RecQ (Kd  2.5mM)
and Sgs1 (Kd  30mM). The surface diagram in Figure
6A (lower panel) depicts how mutations of these
residues reduced the binding afﬁnity of BLM HRDC for
the ssDNA substrate. Mutants K1227E and N1239E
produced an electronegative surface where one was not
desirable, and the Tyr1237, which was the most mobile
site in the dynamics study, lost a large hydrophobic
surface area when changed to Ala. The binding site of
E. coli RecQ HRDC domain, which has the strongest
binding to ssDNA among the three HRDC homologues,
forms a stripe that extends from the conserved hydropho-
bic Tyr555 along an electropositive path including Lys534,
Arg543, Lys544 and Lys587 (Figure 6B). Mutation of the
basic residues to Ala decreased the ssDNA-binding
afﬁnity (lower panel), demonstrating that E. coli HRDC
needs those basic residues to recognize the phosphate
backbone. The Tyr555 side chain is especially important
for E. coli HRDC in interacting with DNA, where replace-
ment with alanine dramatically disrupts the binding
properties (27). NMR titration experiments with Sgs1
HRDC identiﬁed a similar mixture of positively charged
and hydrophobic residues that make up the DNA-binding
surface (Figure 6C). The binding surface is more hydro-
phobic than that of E. coli RecQ but more electropositive
than BLM, and this intermediate distribution explains
why the afﬁnity of Sgs1 for ssDNA is between that of
E. coli RecQ and human BLM (28). The human WRN
HRDC was shown to lack DNA-binding ability in vitro
despite intensive screening (14,30). The WRN HRDC
domain sequence contains a lot of positive and hydropho-
bic residues (Figure 1E), and, as Figure 6D shows, WRN
HRDC also has a positively charged region that includes
Gln1165 and Lys1166 on its surface. However, many of
the hydrophobic residues assemble to form a domain core,
rather than being displayed on the surface of the domain.
Moreover, WRN HRDC possesses additional acidic
residues stacked on top of the domain (29). These differ-
ences suggest that the general HRDC domain structure is
adaptable for multiple DNA-binding modes by virtue of
the distribution of positive charges and hydrophobic
residues on its surface. The HRDC domain can thus
support specialized DNA-binding modes in different
RecQ proteins.
Possible functions of the BLM HRDC domain
While the genomes of bacteria and unicellular eukaryotes
typically encode a single recQ gene, multicellular eukary-
otes express multiple recQ paralogs, each with specialized
functions related to divergent DNA substrates. The most
striking function, unique to BLM among ﬁve human
RecQ helicases, is that BLM, in concert with TOPO
IIIa, processes recombination intermediates containing
dHJs by a process called dHJ dissolution. The dissolution
is highly speciﬁc for BLM among human RecQ helicases
and critically depends upon a functional HRDC domain
in BLM. Furthermore, Lys1270, which is conserved from
E. coli to humans, is predicted to play a role in mediating
interactions with DNA (11). However, surprisingly,
Lys1270 was not a predominant DNA-binding residue
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Lys1270 is located in a site opposite the main
ssDNA-binding groove containing the 310-helical hydro-
phobic loop, adjacent to a highly acidic patch including
Glu1268 and Asp1269, which may explain the reason why
Lys1270 was not involved in ssDNA binding (Figure 7A).
Lys1270 may instead facilitate interactions with other
domains in BLM. A recent study of the DrRecQ HRDC
domain showed that its unusual electrostatic surface
features may be important for inter-domain interactions
that regulate structure-speciﬁc DNA binding and help
direct DrRecQ to speciﬁc recombination/repair sites
(30). The structures of E. coli RNaseD and S. cerevisiae
Rrp6 further demonstrate HRDC domain specialization
(48,49). These ribonuclease structures are of full-length
proteins with HRDC domains and show the tenuous
nature of the inter-domain interactions between their
large, catalytic portions and their HRDC domains. In
both structures, a single acidic residue from the HRDC
domain mediates contacts with the remainder of the
protein. Mutation of this acidic residue in Rrp6 altered
its structure-speciﬁc nuclease activity, attesting to the im-
portance of such inter-domain contacts. Therefore, it may
be that Lys1270 of BLM HRDC has contacts with other
domains in BLM, and so may modulate the enzyme
activity of BLM.
However, the inter-domain model cannot explain how
the single mutation of Lys1270 (K1270V) in BLM HRDC
domain can reduce the efﬁciency of HJ DNA unwinding
without compromising its catalytic efﬁciency for forked-
duplex DNA (15). The prepared HJ DNA is a mobile
HJ which have junction a 12-bp homologous core (33).
The full-size BLM failed to form a stable complex with
linear duplex DNA with a sequence identical to that of
one of the ‘arms’ of the HJ DNA as well as to a similar
DNA molecule of unrelated sequence, indicating that
BLM speciﬁcally interacts with the crossover present in
the synthetic Holliday junction (13). In this study, we
have found that the isolated BLM HRDC preferentially
binds to ssDNA and not dsDNA. It is altogether possible
that isolated BLM HRDC domain binds to the mobile
homologous junction of the prepared HJ. We hypothesize
that the aggregated DNA bands in the EMSA data for HJ
DNA arise from self-repulsion of HRDC, i.e. the surface
charge of HRDC is not being shielded by other domains
as it would be in the full-length BLM protein (Figure 7B).
Interestingly, the crystal structure of the E. coli RuvA–HJ
DNA complex indicates repulsion of HJ DNA by
Figure 6. Comparison of ssDNA-binding residues in HRDC homologues. (A) Human BLM HRDC domain, (B) E. coli RecQ HRDC domain and
(C) S. cerevisiae Sgs1 HRDC domain. (D) Ribbon diagram of human WRN HRDC domain color-coded as in surface diagrams. The protein surface
is colored as follows: positive (blue), negative (red), neutral (yellow) and alanine (green).
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In bacteria, resolution of HJs is accomplished by
the RuvABC system, consisting of a junction-speciﬁc
helicase complex RuvAB, which promotes branch migra-
tion, and a junction-speciﬁc endonuclease RuvC, which
nicks two strands in symmetric form (51). Mutational
studies of the ‘acidic pin’, Glu55 and Asp56, shows that
mutants can modulate the branch migration rate of the
RuvAB complex and markedly reduce the endonuclease
activity of RuvC (50). These results suggest how import-
ant the acidic pin and electronegativity of RuvA is for
binding and processing by the RuvABC resolvasome. In
humans, BLM targets TOPOIIIa to its sites of action on
the DNA, where DNA structures generated by the BLM
helicase are required to be ‘resolved’ by the topoisomerase
(11,14,52). On the basis of our current ﬁndings, we
propose an electrostatic repulsion model to explain how
these conserved acidic patches can be helpful for process-
ing the dHJ DNA by the BLM–TOPOIIIa complex
(Figure 7C). Although we cannot deﬁnitively state the
oligomeric state, electron microscope (EM) images of
human BLM are helpful in proposing this model. In EM
imaging, BLM displays 4-fold symmetry (tetramer or
octamer) and 6-fold (hexamer) symmetry in vitro (53). If
BLM does oligomerize, it is possible that the HRDC
domain from each BLM could use electrical repulsion to
separate the junction sites of dHJ DNA. The BLM oligo-
merization is mediated by the N-terminal region (16). The
BLM helicase core would preferentially bind and unwind
the double stranded region of the dHJ DNA because of its
higher binding afﬁnity for dsDNA and HJ DNA (54).
Then the TOPOIIIa could join the relaxed dHJ DNA–
BLM complex and easily bind to the DNA product.
Finally, the dHJ DNA would be divided into
non-crossover products. Further investigation will be
required to determine whether mutation of the acidic pin
of the BLM HRDC domain can modulate the enzyme
activity of BLM or the BLM–TOPOIIIa complex.
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Figure 7. Electrostatic repulsion model of human BLM HRDC domain. (A) Diametrical views of the acidic pin motif of the human BLM HRDC
domain color-coded as in Figure 1E and rendered with PyMol (Delano Scientiﬁc, San Carlos, CA, 2002). All perturbed DNA-binding residues are
labeled. (B) Schematic diagram of the dissociation of BLM HRDC from HJ by electrostatic repulsion. (C) Mechanism of dHJ DNA dissolution by
BLM–TOPOIIIa complex using electrostatic repulsion. (i) The BLM tetramer binds to dHJ DNA. The HRDC domains (red spheres) recognize the
ssDNA region and the catalytic cores (blue cylinders) bind to the dsDNA region of the dHJ. The N-terminal domains are shown as yellow ellipses.
(ii) The dHJ DNA is separated by electrostatic repulsion of HRDC domains and then TOPOIIIa binds to the relaxed dHJ. (iii) The TOPOIIIa
resolves the dHJ DNA into non-crossover DNA.
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